Cencora, Inc. logo

Cencora, Inc. (ABG)

Market Open
28 Jul, 06:01
XFRA XFRA
286. 10
-1.85
-0.6425%
- Market Cap
23.39 P/E Ratio
2.4% Div Yield
245 Volume
11.93 Eps
287.95
Previous Close
Add Transaction
Day Range
286.1 286.1
Year Range
163.36 344.15
Want to track ABG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ABG trading today lower at €286.1, a decrease of -0.6425% from yesterday's close, completing a monthly decrease of -7.1104% or -€21.9. Over the past 12 months, ABG stock gained 5.9826%.
ABG pays dividends to its shareholders, with the most recent payment made on Jun 01, 2026. The next estimated payment will be in In 1 month on Sep 01, 2026 for a total of €0.6.
The last earnings report, released on May 06, 2026, missed the consensus estimates by -4.75%. On average, the company has fell short of earnings expectations by -1.5833%, based on the last three reports.
Cencora, Inc. has completed 4 stock splits, with the recent split occurring on Jul 18, 2022.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABG Chart

Here's Why You Should Add Cencora Stock to Your Portfolio Now

Here's Why You Should Add Cencora Stock to Your Portfolio Now

COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.

Zacks | 3 days ago
Bet on 5 Top-Ranked Stocks With Rising P/E

Bet on 5 Top-Ranked Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Zacks | 4 days ago
Cencora: Specialty Infrastructure Is Rewriting The Distributor Model

Cencora: Specialty Infrastructure Is Rewriting The Distributor Model

Cencora (COR) is transitioning from a bulk pharmaceutical distributor to a specialty medicines infrastructure provider, targeting higher-margin, service-driven growth. Recent acquisitions of OneOncology and Retina Consultants of America are driving margin expansion, with Q2 adjusted gross profit up 15.7% and margin rising to 4.31%. Management raised FY2026 adjusted EPS guidance to $17.70–$17.90, expects $3B adjusted FCF, and targets 10–14% long-term EPS growth.

Seekingalpha | 5 days ago

Cencora, Inc. (ABG) FAQ

What is the stock price today?

The current price is €286.10.

On which exchange is it traded?

Cencora, Inc. is listed on XFRA.

What is its stock symbol?

The ticker symbol is ABG.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.4%.

What is its market cap?

As of today, no market cap data is available.

Has Cencora, Inc. ever had a stock split?

Cencora, Inc. had 4 splits and the recent split was on Jul 18, 2022.

Cencora, Inc. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Robert Mauch CEO
XFRA Exchange
03073E105 CUSIP
US Country
51,000 Employees
1 Jun 2026 Last Dividend
16 Jun 2009 Last Split
4 Apr 1995 IPO Date

Overview

Cencora, Inc., previously known as AmerisourceBergen Corporation, is a global leader in healthcare solutions, with a focus on improving patient outcomes through the efficient distribution and commercialization of pharmaceuticals and healthcare-related products. Established in 2001 and headquartered in Conshohocken, Pennsylvania, Cencora has expanded its reach by providing a wide range of services to various healthcare providers, including acute care hospitals, retail pharmacies, mail order pharmacies, and specialists across numerous disease states. The company's commitment to offering comprehensive supply chain management services, specialized software, and consulting services underscores its integral role in the healthcare sector. Through its U.S. Healthcare Solutions and International Healthcare Solutions segments, Cencora, Inc. addresses the nuanced needs of its global client base, delivering tailored services that encompass distribution, commercialization, logistics, and much more.

Products and Services

  • Pharmaceutical Distribution - Cencora's core service involves the distribution of pharmaceuticals, including over-the-counter healthcare products, home healthcare supplies and equipment, to a wide range of healthcare providers like hospitals, pharmacies, and clinics. This ensures that essential medicines and healthcare supplies reach those in need efficiently.
  • Pharmacy Management and Consulting Services - Offering pharmacy management, staffing, and consulting services, Cencora supports retail and institutional healthcare providers in optimizing their operations for better service delivery and improved patient care.
  • Supply Management Software - The company provides advanced supply management software solutions that help healthcare providers streamline their operational processes, ensuring that they can focus on patient care without worrying about inventory and supply chain issues.
  • Packaging Solutions - Tailored packaging solutions are offered to healthcare providers, facilitating the safe and reliable distribution of pharmaceuticals and healthcare products.
  • Clinical Trial Support - Supporting biotechnology and pharmaceutical manufacturers with clinical trial support, product post-approval, and commercialization support services, Cencora plays a crucial role in bringing new treatments to market.
  • Data Analytics and Research Services - By providing comprehensive data analytics, outcomes research services, and additional support services, Cencora aids manufacturers and healthcare providers in understanding market trends, patient outcomes, and more, enhancing healthcare delivery.
  • Animal Health Products - The company also caters to the companion animal and production animal markets, offering pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients, supporting veterinary care providers in maintaining animal health.
  • Specialty Products Distribution - Includes the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and specialty products to healthcare providers specializing in various disease states, including oncology.
  • International Healthcare Solutions - Through its international segment, Cencora offers pharmaceutical wholesale, related services, and global commercialization services, emphasizing its role in the international healthcare supply chain. This also includes specialty transportation and logistics services for the biopharmaceutical industry, reflecting the company’s adaptability to the unique needs of global markets.

Contact Information

Address: 1 West First Avenue
Phone: 610 727 7000